{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:22:56Z","timestamp":1792480976797,"version":"4.5.0"},"reference-count":169,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014394","name":"Baylor University Medical Center at Dallas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014394","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jacc.2025.08.036","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:20:42Z","timestamp":1759339242000},"page":"1935-1949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Central Adiposity or Hypertension"],"prefix":"10.1016","volume":"86","author":[{"given":"Milton","family":"Packer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.P.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-1570","authenticated-orcid":false,"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthiah","family":"Vaduganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A.","family":"Borlaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2025.08.036_bib1","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ejhf.2894","volume":"25","author":"Anker","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2025.08.036_bib2","doi-asserted-by":"crossref","first-page":"i115","DOI":"10.1093\/eurheartjsupp\/suae095","article-title":"Towards a phenotype profiling of the patients with heart failure and preserved ejection fraction","volume":"27","author":"Bonfioli","year":"2025","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.jacc.2025.08.036_bib3","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jacc.2025.05.008","article-title":"2025 ACC scientific statement on the management of obesity in adults with heart failure: a report of the American College of Cardiology","volume":"86","author":"Kittleson","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacc.2025.08.036_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033308","article-title":"Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin","volume":"7","author":"Shah","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jacc.2025.08.036_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177175","article-title":"Prediction of whole-body fat percentage and visceral adipose tissue mass from five anthropometric variables","volume":"12","author":"Swainson","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.08.036_bib7","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s00392-021-01822-1","article-title":"Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data","volume":"110","author":"Marcks","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib8","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ijo.2013.203","article-title":"Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data","volume":"38","author":"Padwal","year":"2014","journal-title":"Int J Obes (Lond)"},{"issue":"25","key":"10.1016\/j.jacc.2025.08.036_bib9","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1093\/eurheartj\/ehaf057","article-title":"Near-universal prevalence of central adiposity and its prognostic significance in heart failure with mildly reduced or preserved ejection fraction: the PARAGON-HF trial","volume":"46","author":"Peikert","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.08.036_bib10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/eurheartj\/ehad083","article-title":"Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox","volume":"44","author":"Butt","year":"2023","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.036_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12902-024-01589-2","article-title":"Obesity and metabolic syndrome in patients with heart failure with preserved ejection fraction: a cross-sectional analysis of the Veradigm Cardiology Registry","volume":"24","author":"Bae","year":"2024","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.jacc.2025.08.036_bib12","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.mayocp.2023.07.008","article-title":"Obesity, cardiorenal comorbidities, and risk of hospitalization in patients with heart failure with preserved ejection fraction","volume":"98","author":"Morgen","year":"2023","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2025.08.036_bib13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jacc.2024.10.111","article-title":"Finerenone, obesity, and heart failure with mildly reduced\/preserved ejection fraction: prespecified analysis of FINEARTS-HF","volume":"85","author":"Butt","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.036_bib15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12872-021-02080-9","article-title":"Waist to height ratio is associated with an increased risk of mortality in Chinese patients with heart failure with preserved ejection fraction","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2025.08.036_bib16","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2025.03.530","article-title":"Disentangling the impact of adiposity from insulin resistance in heart failure with preserved ejection fraction","volume":"85","author":"Reddy","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cardfail.2024.06.007","article-title":"Long-term changes in body composition and exercise capacity following calorie restriction and exercise training in older patients with obesity and heart failure with preserved ejection fraction","volume":"31","author":"Upadhya","year":"2025","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib18","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jchf.2018.06.002","article-title":"Regional adipose distribution and its relationship to exercise intolerance in older obese patients who have heart failure with preserved ejection fraction","volume":"6","author":"Haykowsky","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib19","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1177\/2047487319851298","article-title":"Threshold body mass index and sex-specific waist circumference for increased risk of heart failure with preserved ejection fraction","volume":"26","author":"Campbell","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"10.1016\/j.jacc.2025.08.036_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2024-002711","article-title":"Adiposity, fat-free mass and incident heart failure in 500 000 individuals","volume":"11","author":"Oguntade","year":"2024","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2025.08.036_bib21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jchf.2018.07.009","article-title":"Adiposity and incident heart failure and its subtypes: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"6","author":"Rao","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib22","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCULATIONAHA.124.072156","article-title":"Evidence-based application of natriuretic peptides in the evaluation of chronic heart failure with preserved ejection fraction in the ambulatory outpatient setting","volume":"151","author":"Reddy","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.036_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacc.2025.08.036_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011366","article-title":"Uncovering unrecognized heart failure with preserved ejection fraction among individuals with obesity and dyspnea","volume":"17","author":"Kosyakovsky","year":"2024","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib25","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/s41591-024-03140-1","article-title":"An evidence-based screening tool for heart failure with preserved ejection fraction: the HFpEF-ABA score","volume":"30","author":"Reddy","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2025.08.036_bib26","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/ejhf.1250","article-title":"The strengths and limitations of E\/e' in heart failure with preserved ejection fraction","volume":"20","author":"Obokata","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib27","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jchf.2023.01.030","article-title":"Exercise-induced left atrial hypertension in heart failure with preserved ejection fraction","volume":"11","author":"Litwin","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ejhf.1377","article-title":"The conundrum of patients with obesity, exercise intolerance, elevated ventricular filling pressures and a measured ejection fraction in the normal range","volume":"21","author":"Packer","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib29","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.21037\/qims-23-1785","article-title":"Diastolic dysfunction in adults with uncomplicated obesity evaluated with left atrial and left ventricular tissue tracking and ventricular volume-time curve: a prospective cardiac magnetic resonance study","volume":"14","author":"Liu","year":"2024","journal-title":"Quant Imaging Med Surg"},{"key":"10.1016\/j.jacc.2025.08.036_bib30","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib31","first-page":"208","article-title":"The lymphatic drainage of the parietal pericardium in man","volume":"28","author":"Eliskova","year":"1995","journal-title":"Lymphology"},{"key":"10.1016\/j.jacc.2025.08.036_bib32","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1093\/eurheartj\/ehad620","article-title":"Surgical pericardiotomy to treat heart failure with preserved ejection fraction: a first clinical study","volume":"44","author":"Borlaug","year":"2023","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.jacc.2025.08.036_bib33","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jacc.2025.06.055","article-title":"The adipokine hypothesis of heart failure with a preserved ejection fraction: a novel framework to explain pathogenesis and guide treatment","volume":"86","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41401-023-01152-0","article-title":"Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery","volume":"45","author":"Gao","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jacc.2025.08.036_bib35","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacbts.2021.12.009","article-title":"Clinical phenotypes of heart failure with preserved ejection fraction to select preclinical animal models","volume":"7","author":"van Ham","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jacc.2025.08.036_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jacbts.2020.11.012","article-title":"Novel Gottingen miniswine model of heart failure with preserved ejection fraction integrating multiple comorbidities","volume":"6","author":"Sharp","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jacc.2025.08.036_bib37","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jchf.2020.04.016","article-title":"Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction","volume":"8","author":"Koepp","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib38","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/eurheartj\/ehaa823","article-title":"Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction","volume":"42","author":"Sorimachi","year":"2021","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jacc.2025.08.036_bib39","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/ehf2.13382","article-title":"Visceral adiposity, muscle composition, and exercise tolerance in heart failure with preserved ejection fraction","volume":"8","author":"Ying","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib40","article-title":"Clinical features, myocardial strain and tissue characteristics of heart failure with preserved ejection fraction in patients with obesity: a prospective cohort study","volume":"55","author":"He","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"10","key":"10.1016\/j.jacc.2025.08.036_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002883","article-title":"Risk factors for incident hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women","volume":"9","author":"Eaton","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib42","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/ejhf.2291","article-title":"Proteomics to improve phenotyping in obese patients with heart failure with preserved ejection fraction","volume":"23","author":"Kresoja","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib43","first-page":"625","article-title":"Epicardial adipose tissue in heart failure phenotypes - a meta-analysis","volume":"118","author":"Correia","year":"2022","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.amjcard.2022.02.021","article-title":"The quantity of epicardial adipose tissue in patients having ablation for atrial fibrillation with and without heart failure","volume":"172","author":"Wang","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib45","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1002\/ehf2.14483","article-title":"Diverging role of epicardial adipose tissue across the entire heart failure spectrum","volume":"10","author":"Rossi","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib46","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/ejhf.2513","article-title":"Epicardial adipose tissue related to left atrial and ventricular function in heart failure with preserved versus reduced and mildly reduced ejection fraction","volume":"24","author":"Jin","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib47","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/ejhf.2337","article-title":"Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure","volume":"23","author":"Pugliese","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib48","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/CIRCULATIONAHA.117.032474","article-title":"Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity","volume":"137","author":"Packer","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.036_bib49","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/ejhf.1902","article-title":"Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease","volume":"22","author":"Packer","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib50","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/en.2009-0806","article-title":"Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure","volume":"151","author":"Sam","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.jacc.2025.08.036_bib51","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cardiores.2005.04.018","article-title":"Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism","volume":"67","author":"Liao","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2025.08.036_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/aps.2015.84","article-title":"Adiponectin downregulation is associated with volume overload-induced myocyte dysfunction in rats","volume":"37","author":"Wang","year":"2016","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jacc.2025.08.036_bib53","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1124\/mol.112.083964","article-title":"Adiponectin ameliorates iron-overload cardiomyopathy through the PPARalpha-PGC-1-dependent signaling pathway","volume":"84","author":"Lin","year":"2013","journal-title":"Mol Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2025.08.036_bib54","article-title":"Loss of adiponectin-induced renal sodium excretion in hypertension","volume":"10","author":"Huang","year":"2016","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.jacc.2025.08.036_bib55","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCHEARTFAILURE.114.001279","article-title":"Effects of adiponectin on calcium-handling proteins in heart failure with preserved ejection fraction","volume":"7","author":"Tanaka","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib56","doi-asserted-by":"crossref","first-page":"H934","DOI":"10.1152\/ajpheart.00238.2018","article-title":"Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction","volume":"315","author":"Alex","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.036_bib57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12872-017-0509-2","article-title":"Low adiponectin is associated with diastolic dysfunction in women: a cross-sectional study from the Tromso Study","volume":"17","author":"Norvik","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2025.08.036_bib58","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2337\/dc08-1596","article-title":"Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals","volume":"32","author":"Lieb","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.08.036_bib59","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1517\/14728222.2015.1019468","article-title":"Association between plasma leptin and adiponectin levels and diastolic function in the general population","volume":"19","author":"Fontes-Carvalho","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jacc.2025.08.036_bib60","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s11695-009-9924-5","article-title":"Relationship between adiponectin and left atrium size in uncomplicated obese patients: adiponectin, a link between fat and heart","volume":"19","author":"Ybarra","year":"2009","journal-title":"Obes Surg"},{"key":"10.1016\/j.jacc.2025.08.036_bib61","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/CIRCHEARTFAILURE.110.959742","article-title":"Association of adiponectin with left ventricular mass in blacks: the Jackson Heart Study","volume":"4","author":"Bidulescu","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib62","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ijcard.2016.11.194","article-title":"HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin","volume":"228","author":"Fax\u00e9n","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/JME-18-0242","article-title":"Adipose tissue-derived autotaxin causes cardiomyopathy in obese mice","volume":"63","author":"Xu","year":"2019","journal-title":"J Mol Endocrinol"},{"issue":"9","key":"10.1016\/j.jacc.2025.08.036_bib64","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210252","article-title":"PDGF-D activation by macrophage-derived uPA promotes AngII-induced cardiac remodeling in obese mice","volume":"218","author":"Cheng","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jacc.2025.08.036_bib65","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1093\/cvr\/cvab234","article-title":"Resistin deletion protects against heart failure injury by targeting DNA damage response","volume":"118","author":"Zhao","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2025.08.036_bib66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11695-024-07254-w","article-title":"Changes in the structure, function, and fat content of the heart in patients with obesity after bariatric surgery-a prospective magnetic resonance imaging study","volume":"35","author":"Bai","year":"2025","journal-title":"Obes Surg"},{"issue":"5","key":"10.1016\/j.jacc.2025.08.036_bib67","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005126","article-title":"Gastric bypass surgery produces a durable reduction in cardiovascular disease risk factors and reduces the long-term risks of congestive heart failure","volume":"6","author":"Benotti","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.08.036_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.soard.2021.09.009","article-title":"Bariatric surgery decreases the number of future hospital admissions for diastolic heart failure in subjects with severe obesity: a retrospective analysis of the US National Inpatient Sample database","volume":"18","author":"Romero Funes","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.jacc.2025.08.036_bib69","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/oby.22038","article-title":"Bariatric surgery-induced cardiac and lipidomic changes in obesity-related heart failure with preserved ejection fraction","volume":"26","author":"Mikhalkova","year":"2018","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jacc.2025.08.036_bib70","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0140-6736(24)00469-0","article-title":"Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials","volume":"403","author":"Butler","year":"2024","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jacc.2025.08.036_bib71","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jacc.2025.08.036_bib72","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jacc.2025.04.059","article-title":"Impact of body mass index, central adiposity, and weight loss on the effects of tirzepatide in HFpEF: the SUMMIT trial","volume":"86","author":"Borlaug","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib73","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/s41591-023-02526-x","article-title":"Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial","volume":"29","author":"Borlaug","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2025.08.036_bib74","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Wing","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.036_bib75","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.amjcard.2021.01.018","article-title":"Effect of obesity on response to spironolactone in patients with heart failure with preserved ejection fraction","volume":"146","author":"Elkholey","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib76","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM197210192871601","article-title":"Role of blood pressure in the development of congestive heart failure. The Framingham study","volume":"287","author":"Kannel","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.036_bib77","article-title":"Age dependent associations of risk factors with heart failure: pooled population based cohort study","volume":"372","author":"Tromp","year":"2021","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.jacc.2025.08.036_bib78","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008322","article-title":"SPRINT Research Group. Incidence and outcomes of acute heart failure with preserved versus reduced ejection fraction in SPRINT","volume":"14","author":"Upadhya","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib79","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1161\/CIRCULATIONAHA.110.012575","article-title":"Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"124","author":"Piller","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.036_bib80","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCHEARTFAILURE.112.972828","article-title":"Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction","volume":"6","author":"Ho","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib81","doi-asserted-by":"crossref","first-page":"R803","DOI":"10.1152\/ajpregu.00707.2003","article-title":"Obesity and hypertension: two epidemics or one?","volume":"286","author":"Davy","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"9","key":"10.1016\/j.jacc.2025.08.036_bib82","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3390\/genes15091126","article-title":"A multivariable Mendelian randomization study of systolic and diastolic blood pressure, lipid profile, and heart failure subtypes","volume":"15","author":"Liu","year":"2024","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.036_bib83","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12933-025-02738-0","article-title":"Circulating mediators linking cardiometabolic diseases to HFpEF: a mediation Mendelian randomization analysis","volume":"24","author":"Lin","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacc.2025.08.036_bib84","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/FJC.0b013e3182102c3b","article-title":"Cardiovascular changes during maturation and ageing in male and female spontaneously hypertensive rats","volume":"57","author":"Chan","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl N","key":"10.1016\/j.jacc.2025.08.036_bib85","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/eurheartj\/16.suppl_N.19","article-title":"The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure","volume":"16","author":"Boluyt","year":"1995","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.jacc.2025.08.036_bib86","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015009","article-title":"Phenotyping heart failure according to the longitudinal ejection fraction change: myocardial strain, predictors, and outcomes","volume":"9","author":"Park","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.08.036_bib87","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41440-024-02025-7","article-title":"Establishment of a HFpEF model using female Dahl salt-sensitive rats: a valuable tool for elucidating the pathophysiology of HFpEF in women","volume":"48","author":"Nakashima","year":"2025","journal-title":"Hypertens Res"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.036_bib88","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41598-024-84515-9","article-title":"Two-hit mouse model of heart failure with preserved ejection fraction combining diet-induced obesity and renin-mediated hypertension","volume":"15","author":"Berger","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2025.08.036_bib89","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1093\/eurheartj\/ehab389","article-title":"Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models","volume":"42","author":"Withaar","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.08.036_bib90","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jash.2013.08.005","article-title":"Contribution of obesity to left atrial and left ventricular dysfunction in asymptomatic patients with hypertension: A two-dimensional speckle-tracking echocardiographic study","volume":"8","author":"Miyoshi","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.jacc.2025.08.036_bib91","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.036_bib92","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/jama.1997.03550030052033","article-title":"Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension","volume":"278","author":"Kostis","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.08.036_bib93","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/01.HYP.33.6.1476","article-title":"Update on the systolic hypertension in Europe (Syst-Eur) trial","volume":"33","author":"Staessen","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.08.036_bib94","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged 75 years: a randomized clinical trial","volume":"315","author":"Williamson","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.08.036_bib95","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJMoa2412006","article-title":"Intensive blood-pressure control in patients with type 2 diabetes","volume":"392","author":"Bi","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.036_bib96","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(24)01028-6","article-title":"Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial","volume":"404","author":"Liu","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.036_bib97","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jamacardio.2024.1449","article-title":"Multifaceted intensive blood pressure control model in older and younger individuals with hypertension: a randomized clinical trial","volume":"9","author":"Guo","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib98","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.maturitas.2023.04.009","article-title":"Intensive blood pressure control for patients aged over 60: a meta-analysis of the SPRINT, STEP, and ACCORD BP randomized controlled trials","volume":"172","author":"Li","year":"2023","journal-title":"Maturitas"},{"key":"10.1016\/j.jacc.2025.08.036_bib99","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.036_bib100","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.036_bib101","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/ajh\/hpw119","article-title":"Second Australian National Blood Pressure Study Management Committee. Prediction of 10-year risk of incident heart failure in elderly hypertensive population: the ANBP2 study","volume":"30","author":"Sahle","year":"2017","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.08.036_bib102","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/HYPERTENSIONAHA.111.00163","article-title":"Carotid arterial stiffness and its relationship to exercise intolerance in older patients with heart failure and preserved ejection fraction","volume":"61","author":"Kitzman","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.08.036_bib103","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/ehf2.14422","article-title":"Rising arterial stiffness with accumulating comorbidities associates with heart failure with preserved ejection fraction","volume":"10","author":"Ali","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib104","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/ehf2.15228","article-title":"Sex-related pathophysiological mechanisms may be present before symptoms of HFpEF develop","volume":"12","author":"Wong","year":"2025","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib105","doi-asserted-by":"crossref","DOI":"10.1113\/JP287094","article-title":"Vascular remodelling in a mouse model of heart failure with preserved ejection fraction","author":"Sanhueza-Olivares","year":"2025","journal-title":"J Physiol"},{"issue":"4","key":"10.1016\/j.jacc.2025.08.036_bib106","article-title":"Association of cardiac MRI-derived aortic stiffness with early stages and progression of heart failure with preserved ejection fraction","volume":"6","author":"Schulz","year":"2024","journal-title":"Radiol Cardiothorac Imaging"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.036_bib107","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12872-022-02679-6","article-title":"The relationship between ambulatory arterial stiffness index and left ventricular diastolic dysfunction in HFpEF: a prospective observational study","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2025.08.036_bib108","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41371-022-00703-y","article-title":"Association of arterial stiffness and heart failure with preserved ejection fraction in the elderly population - results from the CARLA study","volume":"37","author":"Schott","year":"2023","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jacc.2025.08.036_bib109","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cardfail.2021.10.019","article-title":"Arterial stiffness and vascular load in HFpEF: differences among women and men","volume":"28","author":"Lau","year":"2022","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib110","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1152\/japplphysiol.00458.2019","article-title":"Elevated exercise blood pressure in middle-aged women is associated with altered left ventricular and vascular stiffness","volume":"128","author":"Sarma","year":"2020","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.jacc.2025.08.036_bib111","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cardfail.2021.02.011","article-title":"Exercise intolerance in heart failure with preserved ejection fraction: arterial stiffness and abnormal left ventricular hemodynamic responses during exercise","volume":"27","author":"Zern","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib112","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2147\/DMSO.S399928","article-title":"Association between visceral fat, blood pressure and arterial stiffness in patients with HFpEF: a mediation analysis","volume":"16","author":"Sun","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jacc.2025.08.036_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2022.111726","article-title":"Relationship between adipose tissue distribution and arterial stiffness in HFpEF","volume":"102","author":"Hu","year":"2022","journal-title":"Nutrition"},{"key":"10.1016\/j.jacc.2025.08.036_bib114","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2147\/DMSO.S356001","article-title":"EAT thickness as a predominant feature for evaluating arterial stiffness in patients with heart failure with preserved ejection fraction","volume":"15","author":"Liu","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jacc.2025.08.036_bib115","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/HYPERTENSIONAHA.109.147850","article-title":"Arterial destiffening with weight loss in overweight and obese middle-aged and older adults","volume":"55","author":"Dengo","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.08.036_bib116","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jchf.2014.03.014","article-title":"Impact of general and central adiposity on ventricular-arterial aging in women and men","volume":"2","author":"Wohlfahrt","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib117","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCHEARTFAILURE.113.000383","article-title":"Longitudinal changes in left ventricular stiffness: a community-based study","volume":"6","author":"Borlaug","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib118","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fendo.2019.00584","article-title":"Role of aldosterone and mineralocorticoid receptor in cardiovascular aging","volume":"10","author":"Gorini","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jacc.2025.08.036_bib119","doi-asserted-by":"crossref","first-page":"R387","DOI":"10.1152\/ajpregu.00235.2016","article-title":"Cellular mechanisms underlying obesity-induced arterial stiffness","volume":"314","author":"Aroor","year":"2018","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib120","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/cvr\/cvx097","article-title":"The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall","volume":"113","author":"Jia","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2025.08.036_bib121","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(12)61343-9","article-title":"Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial","volume":"381","author":"Weber","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.036_bib122","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/CIRCULATIONAHA.107.762229","article-title":"Heart failure with preserved and reduced left ventricular ejection fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial","volume":"118","author":"Davis","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.036_bib123","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","article-title":"ALLHAT Collaborative Research Group Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"283","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.08.036_bib124","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.08.036_bib125","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(14)61171-5","article-title":"Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials","volume":"385","author":"Ying","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.036_bib126","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jacc.2024.11.007","article-title":"Systolic blood pressure and pulse pressure in heart failure: pooled participant-level analysis of 4 trials","volume":"85","author":"Lu","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib127","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pcad.2022.06.009","article-title":"Initiation of anti-hypertensive drugs and outcomes in patients with heart failure with preserved ejection fraction and persistent hypertension","volume":"73","author":"Lam","year":"2022","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2025.08.036_bib128","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jchf.2022.04.006","article-title":"Apparent treatment-resistant hypertension across the spectrum of heart failure phenotypes in the Swedish HF registry","volume":"10","author":"Jackson","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib129","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(21)01921-8","article-title":"Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.036_bib130","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.036_bib131","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.08.036_bib132","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.036_bib133","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1093\/eurheartj\/ehab499","article-title":"Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction","volume":"42","author":"Jackson","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.08.036_bib134","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jacc.2020.02.009","article-title":"Systolic blood pressure in heart failure with preserved ejection fraction treated with sacubitril\/valsartan","volume":"75","author":"Selvaraj","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib135","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.036_bib136","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.036_bib137","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ejhf.1060","article-title":"Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trial","volume":"20","author":"Selvaraj","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib138","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/ajh\/hpx210","article-title":"Spironolactone and resistant hypertension in heart failure with preserved ejection fraction","volume":"31","author":"Rossignol","year":"2018","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2025.08.036_bib139","first-page":"1304","article-title":"Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction: the EMPEROR-Preserved trial","volume":"46","author":"B\u00f6hm","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.08.036_bib140","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/eurheartj\/ehac693","article-title":"Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial","volume":"44","author":"B\u00f6hm","year":"2023","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.jacc.2025.08.036_bib141","doi-asserted-by":"crossref","first-page":"350","DOI":"10.21037\/atm.2017.06.69","article-title":"Association of obesity with hypertension","volume":"5","author":"Aronow","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jacc.2025.08.036_bib142","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0091-7435(87)90087-9","article-title":"Incidence and precursors of hypertension in young adults: the Framingham Offspring Study","volume":"16","author":"Garrison","year":"1987","journal-title":"Prev Med"},{"key":"10.1016\/j.jacc.2025.08.036_bib143","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms","volume":"116","author":"Hall","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2025.08.036_bib144","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41581-019-0145-4","article-title":"Obesity, kidney dysfunction and hypertension: mechanistic links","volume":"15","author":"Hall","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jacc.2025.08.036_bib145","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","article-title":"Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction","volume":"59","author":"Briones","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.08.036_bib146","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10157-010-0298-8","article-title":"Activation of the aldosterone\/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome","volume":"14","author":"Nagase","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jacc.2025.08.036_bib147","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/00015385.2019.1598638","article-title":"Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities","volume":"75","author":"Di Chiara","year":"2020","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib148","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijcard.2011.06.061","article-title":"Adiponectin and progression of arterial stiffness in hypertensive patients","volume":"163","author":"Youn","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib149","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/HYPERTENSIONAHA.107.086835","article-title":"Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study","volume":"49","author":"Chow","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.08.036_bib150","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/oby.2000.32","article-title":"Overweight, obesity, and blood pressure: the effects of modest weight reduction","volume":"8","author":"Mertens","year":"2000","journal-title":"Obes Res"},{"key":"10.1016\/j.jacc.2025.08.036_bib151","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/cen.14203","article-title":"Obesity predicts persistence of resistant hypertension after surgery in patients with primary aldosteronism","volume":"93","author":"Nakamaru","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jacc.2025.08.036_bib152","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.HYP.36.4.594","article-title":"Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community","volume":"36","author":"Lloyd-Jones","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.08.036_bib153","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40292-018-0284-x","article-title":"Blood pressure control and other quality of care metrics for patients with obesity and diabetes: a population-based cohort study","volume":"25","author":"Fink","year":"2018","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.jacc.2025.08.036_bib154","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/archfami.8.3.228","article-title":"Predictors and mediators of successful long-term withdrawal from antihypertensive medications. TONE Cooperative Research Group. Trial of Nonpharmacologic Interventions in the Elderly","volume":"8","author":"Espeland","year":"1999","journal-title":"Arch Fam Med"},{"issue":"1","key":"10.1016\/j.jacc.2025.08.036_bib155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12872-025-04640-9","article-title":"The role of bariatric surgery in hypertension control: a systematic review and meta-analysis with extended benefits on metabolic factors","volume":"25","author":"Dastjerdi","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.jacc.2025.08.036_bib156","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41591-024-03374-z","article-title":"Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial","volume":"31","author":"Borlaug","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2025.08.036_bib157","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1161\/HYPERTENSIONAHA.124.23054","article-title":"Antihypertensive medication use trajectories after bariatric surgery: a matched cohort study","volume":"81","author":"Passman","year":"2024","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.jacc.2025.08.036_bib158","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jacc.2024.11.001","article-title":"Tirzepatide reduces LV mass and paracardiac adipose tissue in obesity-related heart failure: SUMMIT CMR substudy","volume":"85","author":"Kramer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib159","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2023.03.024","article-title":"Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease","volume":"379","author":"Burger","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib160","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jacc.2017.05.029","article-title":"Arterial stiffening with exercise in patients with heart failure and preserved ejection fraction","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib161","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1001\/jama.2021.18463","article-title":"Effect of sacubitril\/valsartan vs standard medical therapies on plasma NT-proBNP concentration and submaximal exercise capacity in patients with heart failure and preserved ejection fraction: the PARALLAX randomized clinical trial","volume":"326","author":"Pieske","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.08.036_bib162","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.08.036_bib163","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM198501313120504","article-title":"Hypertensive hypertrophic cardiomyopathy of the elderly","volume":"312","author":"Topol","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.08.036_bib164","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00392-025-02620-9","article-title":"Heart failure with supranormal ejection fraction: clinical characteristics and outcomes compared to mildly reduced and preserved ejection fraction","volume":"114","author":"Segev","year":"2025","journal-title":"Clin Res Cardiol"},{"issue":"6","key":"10.1016\/j.jacc.2025.08.036_bib165","article-title":"Characterizing heart failure across the spectrum of the preserved ejection fraction: does heart failure with supranormal ejection fraction exist? Data from the Swedish Heart Failure Registry","volume":"14","author":"Landucci","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.08.036_bib166","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0735-1097(89)90596-2","article-title":"Hypertensive hypertrophic cardiomyopathy or hypertrophic cardiomyopathy with hypertension? A study of 78 patients","volume":"13","author":"Karam","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.08.036_bib167","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/ejhf.147","article-title":"Impaired left atrial function in heart failure with preserved ejection fraction","volume":"16","author":"Santos","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib168","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/CIRCULATIONAHA.122.059280","article-title":"Characteristics of heart failure with preserved ejection fraction across the range of left ventricular ejection fraction","volume":"146","author":"Rosch","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.08.036_bib169","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ejhf.2843","article-title":"Ventricular stiffening and chamber contracture in heart failure with higher ejection fraction","volume":"25","author":"Popovic","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2025.08.036_bib170","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/HYPERTENSIONAHA.113.01445","article-title":"Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging","volume":"62","author":"AlGhatrif","year":"2013","journal-title":"Hypertension"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725075011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725075011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T01:24:37Z","timestamp":1766193877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725075011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":169,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0735109725075011"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.08.036","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central Adiposity or Hypertension","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.08.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}